Foresite Capital Management I 13F annual report

Foresite Capital Management I is an investment fund managing more than $33.9 million ran by James Tananbaum. There is currently 1 company in Mr. Tananbaum’s portfolio. The largest and only investment include 10x Genomics worth $33.9 million.

$33.9 million Assets Under Management (AUM)

As of 5th August 2022, Foresite Capital Management I’s top holding is 750,000 shares of 10x Genomics currently worth over $33.9 million and making up 100.0% of the portfolio value. Relative to the number of outstanding shares of 10x Genomics, Foresite Capital Management I owns more than approximately 0.1% of the company.

Currently, Foresite Capital Management I's portfolio is worth at least $33.9 million. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Foresite Capital Management I

The Foresite Capital Management I office and employees reside in Larkspur, California. According to the last 13-F report filed with the SEC, James Tananbaum serves as the Managing Member at Foresite Capital Management I.

Recent trades

There are companies that Foresite Capital Management I is getting rid of from its portfolio. Foresite Capital Management I closed its position in Epizyme Inc on 12th August 2022. It sold the previously owned 143,759 shares for $165 thousand.

One of the smallest hedge funds

The two most similar investment funds to Foresite Capital Management I are Act Ii Management, L.P. and Lyons Wealth Management,. They manage $33.8 million and $34.1 million respectively.

James Tananbaum investment strategy

Foresite Capital Management I’s portfolio is diversified across 1 sector. Currently, their heaviest sector is Health Care — making up 100.0% of the total portfolio value. The fund focuses on investments in the United States as 100.0% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up approximately 0.1% of the total holdings value. On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio. The average market cap of the portfolio companies is close to $5.4 billion.

The complete list of Foresite Capital Management I trades based on 13F SEC filings

These positions were updated on August 12th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security	Shares Owned	Value	Allocation
10x Genomics, Inc.	No change 750,000	$33,938,000	100.00%
Epizyme Inc	Closed 143,759	$165,000
No transactions found
Showing first 500 out of 2 holdings